Table 1.
Demographic and health characteristics of intervention conditions
| Variable | FAST Intervention (n = 119) | Control Intervention (n = 109) | t-test | χ2 | p-value |
|---|---|---|---|---|---|
| Age, M (SD) | 53.0 (7.8) | 52.2 (7.1) | 0.79 | .43 | |
| Education (years), M (SD) | 11.6 (2.8) | 11.7 (2.6) | −0.09 | .93 | |
| Female, n (%) | 47 (39.5) | 36 (33.0) | 1.03 | .31 | |
| Caucasian, n (%) | 61 (51.3) | 59 (54.1) | 0.19 | .67 | |
| Schizoaffective*, n (%) | 23 (19.3) | 20 (18.5) | 0.02 | .88 | |
| Daily neuroleptic dosea, M (SD) | 462.3 (497.2) | 424.7 (394.6) | 0.59 | .56 | |
| Any emergency service use, n (%) | 18 (15.1) | 20 (18.3) | 0.43 | .51 | |
| Emergency Psychiatric use*, n (%) | 11 (9.3) | 13 (11.9) | 0.41 | .52 | |
| PANSS Total, M (SD) | 58.4 (15.3) | 62.3 (17.2) | −1.85 | .07 | |
| HAMD Total, M (SD) | 10.3 (7.4) | 10.4 (6.8) | −0.08 | .94 | |
| DRS Total, M (SD) | 125.2 (13.0) | 125.4 (15.0) | −0.09 | .93 |
*
n = 227.
a
Daily Neuroleptic Dose (n = 206) is reported as mg chlorpromazine equivalent (Jeste & Wyatt, 1982; Woods, 2003).